| # | Drug | Count |
|---|---|---|
| 0 | VENLAFAXINE | 9 |
| 1 | VENLAFAXINE HYDROCHLORIDE | 9 |
| 2 | ZIDOVUDINE | 8 |
| 3 | CEFIXIME | 7 |
| 4 | DARIDOREXANT | 7 |
| 5 | FERROUS SULFATE | 7 |
| 6 | OLANZAPINE | 7 |
| 7 | FLUTICASONE PROPIONATE | 6 |
| 8 | FLUTICASONE PROPIONATE NASAL | 6 |
| 9 | IMMUNE GLOBULIN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DARIDOREXANT | 7 | 0.0025 |
| 1 | NELFINAVIR MESYLATE | 5 | 0.0024 |
| 2 | CEFIXIME | 7 | 0.0023 |
| 3 | PORACTANT ALFA | 1 | 0.0014 |
| 4 | ZINC SULFATE INJECTION, | 3 | 0.0010 |
| 5 | ZINC SULFATE INJECTION | 3 | 0.0010 |
| 6 | SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM LACTATE AND CALCIUM CHLORIDE | 1 | 0.0010 |
| 7 | ZIDOVUDINE | 8 | 0.0008 |
| 8 | CLOMIPRAMINE HYDROCHLORIDE | 2 | 0.0004 |
| 9 | LAMIVUDINE AND ZIDOVUDINE | 3 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Surfactant [EPC] | 1 | 0.0009 |
| 1 | Orexin Receptor Antagonist [EPC] | 7 | 0.0004 |
| 2 | Oxytocic [EPC] | 1 | 0.0003 |
| 3 | Human Immunoglobulin G [EPC] | 5 | 0.0002 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0001 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0001 |
| 8 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Polyene Antifungal [EPC] | 1 | 0.0000 |